1. Home
  2. RVNC vs MTA Comparison

RVNC vs MTA Comparison

Compare RVNC & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • MTA
  • Stock Information
  • Founded
  • RVNC 1999
  • MTA N/A
  • Country
  • RVNC United States
  • MTA Canada
  • Employees
  • RVNC N/A
  • MTA N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • MTA
  • Sector
  • RVNC Health Care
  • MTA
  • Exchange
  • RVNC Nasdaq
  • MTA Nasdaq
  • Market Cap
  • RVNC 292.5M
  • MTA 285.5M
  • IPO Year
  • RVNC 2014
  • MTA N/A
  • Fundamental
  • Price
  • RVNC $3.64
  • MTA $3.05
  • Analyst Decision
  • RVNC Buy
  • MTA
  • Analyst Count
  • RVNC 9
  • MTA 0
  • Target Price
  • RVNC $12.00
  • MTA N/A
  • AVG Volume (30 Days)
  • RVNC 2.0M
  • MTA 240.0K
  • Earning Date
  • RVNC 08-06-2024
  • MTA 08-09-2024
  • Dividend Yield
  • RVNC N/A
  • MTA 0.75%
  • EPS Growth
  • RVNC N/A
  • MTA N/A
  • EPS
  • RVNC N/A
  • MTA N/A
  • Revenue
  • RVNC $236,645,000.00
  • MTA $3,580,147.00
  • Revenue This Year
  • RVNC $20.63
  • MTA $70.01
  • Revenue Next Year
  • RVNC $34.80
  • MTA $109.43
  • P/E Ratio
  • RVNC N/A
  • MTA N/A
  • Revenue Growth
  • RVNC 54.59
  • MTA 78.68
  • 52 Week Low
  • RVNC $2.30
  • MTA $2.32
  • 52 Week High
  • RVNC $24.87
  • MTA $4.74
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 60.00
  • MTA 52.56
  • Support Level
  • RVNC $3.56
  • MTA $2.81
  • Resistance Level
  • RVNC $4.38
  • MTA $3.32
  • Average True Range (ATR)
  • RVNC 0.30
  • MTA 0.13
  • MACD
  • RVNC 0.13
  • MTA 0.03
  • Stochastic Oscillator
  • RVNC 62.53
  • MTA 56.35

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Share on Social Networks: